Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16)

Fig. 2

A Comparison of OS in patients with CBF-AML according chemotherapy courses. B Comparison of CIR in patients with CBF-AML according chemotherapy courses. C Comparison of OS in patients with inv(16) according chemotherapy courses. D Comparison of CIR in patients with inv(16) according chemotherapy courses (E)Comparison of OS in patients with t(8;21) according chemotherapy course. F Comparison of CIR in patients with t(8;21) according chemotherapy course

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us